(Q39428126)
Statements
1 reference
The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study (English)
2 references
The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled Study (English)
M. Caine
S. Perlberg
1 October 1975
1 reference
1 reference
114
1 reference
4
1 reference
564-568
1 reference
91
427
A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4′-nitro-3′-trifluoromethylisobutyranilide) (English)
Neri
1972
94
532
On the mechanism of the anti-androgenic action of flutamide (α-α-α-trifluoro-2-methyl-4′-nitro-m-propionotoluidide) in the rat (English)
Peets
1974
1
113
An investigation into the antiandrogenic properties of the non-steroidal compound, SCH 13521 (English)
Mainwaring
1974
107
289
Urinary dynamics in benign prostatic hypertrophy (English)
Castro
1972
2
598
Significance of signs and symptoms in benign prostatic hypertrophy (English)
Castro
1969
111
803
SCH 13521 in the treatment of advanced carcinoma of the prostate (English)
Stoliar
1974
Identifiers
1 reference